MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...

MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...

Optec International, Inc. engages in selling and marketing optimized fuel maximizer units in North America and internationally. It markets optimized fuel maximizer for passenger vehicles, intermediate ...

When people come together and talk about really interesting topics, great questions spark better understanding and opportunities for new ideas to form. On The Spark from WITF, host Asia Tabb starts ...

MSD's booth is seen during an expo in Shanghai in November. [PHOTO/CHINA DAILY] With a long-term commitment to the Chinese market, United States-based global pharmaceutical company MSD plans to ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

(Alliance News) - OptiBiotix Health PLC on Monday said it has received a first order from a "well-known" weight management company following an agreement announced in August. Read More ...